Navigation Links
Simvastatin Plus Niacin May Lower Heart Risks

Treatment combining the cholesterol drug simvastatin with the B vitamin niacin lowers the risk of heart attack and other artery-disease complications by up to 90% in some patients. The study of 160 adults with clogged heart arteries and low HDL (good) cholesterol showed that 3 years of the combo treatment improved HDL levels, caused artery blockages to recede and significantly lowered heart complications compared with an inactive placebo. //

Both lowering LDL, the "bad" cholesterol, and raising HDL help lower the risk of cardiac "events" such as heart attack. Brown, a researcher at the University of Washington in Seattle, and his colleagues reasoned that cutting LDL with a statin drug and raising HDL with niacin could potentially double the benefits for at-risk patients. And since low HDL may reflect an antioxidant deficiency, treatment with such vitamins could be expected to confer still more protection.

In the study, patients took either a combination of simvastatin (Zocor) and niacin alone, antioxidants alone, simvastatin-niacin plus antioxidants, or placebo. The antioxidant treatment included vitamins E, C, beta-carotene and selenium. Over 3 years, patients on simvastatin-niacin were 60% to 90% less likely than placebo patients to have a heart attack or stroke, need artery-clearing surgery or to die from causes related to their artery disease. These patients also showed a slight regression in their artery blockages, while on average all of the other groups showed worsening artery narrowing.

Patients on the combination plus antioxidants had more artery narrowing after 3 years and their HDL increases were not as strong compared with patients on simvastatin-niacin alone. Their risk of cardiac complications was lower, but not as low as that of patients on the combination alone. Treatment with antioxidants alone actually lowered an HDL component called HDL2 and did not cut patients' risk of heart attack and other complications.


'"/>




Related medicine news :

1. Ranbaxy Gets USFDA Nod For Simvastatin
2. Niacin Safe for Diabetics
3. Ritalin May Lower Cocaine Abuse
4. Eating More Often May Help Lower Cholesterol
5. Lower surgical volume linked to higher death rate
6. Lowering blood pressure beneficial for PAD patients
7. Lower chance of bone fracture with Vitamin D supplementation
8. Tea Pill Lowers Cholesterol
9. Aspirin Lowers Leukemia Risk
10. Almonds Help Lower Cholesterol
11. Lowering Risk of Breast Cancer Recurrence
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/11/2016)... ... February 11, 2016 , ... The Commission ... for the Board of Commissioners. Individuals interested in volunteer board service are encouraged ... of clinical practice settings and across allied health to contribute to its mission ...
(Date:2/11/2016)... ... February 11, 2016 , ... PharmMD ... Counsel. Garrett will focus on contract negotiations, corporate strategy and healthcare data law. ... and best practices in data breaches for the Part D Star Rating improvement ...
(Date:2/11/2016)... Orange City, FL (PRWEB) , ... February 11, ... ... has announced the commencement of a master charity program created to assist the ... every 60 days, working closely with nonprofit organizations and community leaders. Their hope ...
(Date:2/11/2016)... ... 11, 2016 , ... AccuVein Inc. announces the Infusion Nurses ... Practice, to include vascular visualization as a standard practice. AccuVein ( http://www.accuvein.com ), ... market, facilitates adherence to this standard with its easy to use, widely deployed ...
(Date:2/11/2016)... TX (PRWEB) , ... February 11, 2016 , ... ... surrounding communities with their ongoing community involvement program, introduces a new charity campaign ... hospitalized children, donations are now being accepted at https://donate.rmhc.org/ . , Ronald ...
Breaking Medicine News(10 mins):
(Date:2/11/2016)... North America , ... The global market is expected to reach USD 20,190.1 Million by ... of 10.2%. --> North America , ... MarketsandMarkets, The global market is expected to reach USD 20,190.1 Million ... CAGR of 10.2%. --> According to a new market ...
(Date:2/11/2016)... , February 11, 2016 ... Market Report 2016 research report provides information on ... development status with crucial statistical data and information ... http://www.deepresearchreports.com/142870.html . --> Complete report on ... companies and supported with 296 tables and figures ...
(Date:2/10/2016)... , Feb. 11, 2016  QT Vascular Ltd., together ... and together with its subsidiaries, the "Group"), is ... litigation with AngioScore, Inc. ("ÄngioScore") (now owned by ... the United States Court ... Circuit") reversed an earlier district court order (the ...
Breaking Medicine Technology: